2013-10-09 13:24:31 UTC

PENTAX Medical Supports AGA’s Technology Initiatives

Bethesda, MD (Oct. 9, 2013) — Today, the American Gastroenterological Association (AGA) Institute announced a new partnership with PENTAX Medical. PENTAX Medical will provide substantial funding over three years to stimulate innovation that will advance the science and practice of gastroenterology and improve patient outcomes.

“We are proud to partner with PENTAX Medical, an organization committed to improving patient care through innovative medical technologies,” said Anil K. Rustgi, MD, AGAF, president, AGA Institute. “This generous gift will help the AGA Institute in developing essential programming to advance innovation in gastroenterology, with the ultimate goal of developing new ways to care for patients suffering from digestive diseases.”

PENTAX Medical will become a three-year sponsor of AGA’s annual technology summit, which serves to identify unmet needs in gastroenterology, highlight promising new technologies, and deliver vital information on what it takes to obtain approval, adoption, coverage and reimbursement in today’s health-care environment.

PENTAX Medical’s commitment will also support the AGA Center for GI Innovation and Technology in its global efforts to foster innovation and technology in digestive and metabolic diseases under the principles of evidence-based medicine. The center supports innovation in the development of new technology in gastroenterology, hepatology, nutrition and obesity by guiding medical device and therapeutics innovators though the technology development and adoption process.

Furthering its commitment to GI innovation, PENTAX Medical will also support AGA Research Foundation’s Corporate Roundtable, which engages corporate and clinical GI leaders in discussions regarding scientific advancements, policy, legislation, and other issues and opportunities that impact the science and practice of gastroenterology and hepatology.

“PENTAX Medical is pleased to support the AGA Institute in its work to promote innovation in gastroenterology,” said Len Farris, vice president of marketing, Americas, PENTAX Medical. “By investing in the AGA Institute, we are putting innovation in the hands of GI clinicians who are at the forefront of battling digestive diseases. We look forward to the technological discoveries that will result from this collaboration.”


About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org

Follow us on Twitter @AmerGastroAssn.
Become an AGA fan on Facebook.
Join AGA on LinkedIn.
Check out our videos on YouTube.

About the AGA Research Foundation

The AGA Research Foundation, formerly known as the Foundation for Digestive Health and Nutrition, is the cornerstone of AGA’s effort to expand digestive disease research funding. Since 1984, the AGA, through its foundations, has provided more than $40 million in research grants to more than 770 scientists. The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of young researchers between the end of training and the establishment of credentials that earn National Institutes of Health grants. Learn more about the AGA Research Foundation or make a contribution at www.gastro.org/foundation.

About PENTAX Medical

PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs. www.pentaxmedical.com